top of page
Clinical Trial
The team at Actym is committed to advancing safe and efficacious treatments initially for patients who are suffering from solid tumors. Our technology has been developed with the patient’s health in mind, to achieve an unprecedented level of therapeutic impact for patients across multiple oncology and non-oncology indications.
Actym is currently evaluating ACTM-838 in a phase 1a/1b clinical trial in patients with advanced solid tumors.
bottom of page